INCRELEX mecasermin 10 mg/mL (40mg/4mL) solution for injection vial (Esteve Pharmaceuticals, UK)
Section 19A approved medicine
INCRELEX mecasermin 10 mg/mL (40mg/4mL) solution for injection vial (Esteve Pharmaceuticals, UK)
Section 19A approval holder
Asteri Pharma Pty Ltd ABN 69 665 948 158
Phone
1800 175 659
Approved until
Status
Current
Medicines in short supply/unavailable
INCRELEX mecasermin 10 mg/mL solution for injection vial - ARTG 308494
Indication(s)
For the long-term treatment of growth failure in children and adolescents from 2 to 18 years with severe primary insulin-like growth factor 1 deficiency (Primary IGFD).
Images
